|
|
|
|
| LEADER |
03224nmm a2200361 u 4500 |
| 001 |
EB000682363 |
| 003 |
EBX01000000000000000535445 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642955136
|
| 100 |
1 |
|
|a Schlag, G.
|e [editor]
|
| 245 |
0 |
0 |
|a Fibrin Sealant in Operative Medicine
|h Elektronische Ressource
|b Volume 6 General Surgery and Abdominal Surgery
|c edited by G. Schlag, H. Redl
|
| 250 |
|
|
|a 1st ed. 1986
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1986, 1986
|
| 300 |
|
|
|a XVII, 204 p
|b online resource
|
| 505 |
0 |
|
|a A Comparative Study -- Survey of Liver Regeneration Following Liver Resection by Application of Fibrin Sealant -- Experience with the Use of Fibrin Sealing in Surgical Therapy of Liver Tumours -- Splenic Salvage by the Use of Fibrin Tissue Adhesive --
|
| 505 |
0 |
|
|a A Comparative Investigation -- The Use of Fibrin Sealant (Tissucol/Tisseel) in Manual and Stapled Anastomoses -- Colonic Anastomoses Protected with Fibrin Sealant (Tissucol/Tisseel) -- Fibrin Adhesive in Colorectal Surgery -- From Conventional Suturing to Sutureless Anastomoses in General Surgery -- Endoscopic Therapy of Fistulae with Fibrin Tissue Sealant -- Lymph Fistulae Following Lymph Node Dissections: Avoidance and Treatment by Use of Fibrin Sealing -- Fibrin Sealant in Skin Necroses Induced by Cytostatic Drugs and in Superinfected Wounds --
|
| 505 |
0 |
|
|a An Animal Experiment -- Haemostatic Effect of Fibrin Sealant in Patients with Congenital and Acquired Bleeding Disorders
|
| 653 |
|
|
|a General Surgery
|
| 653 |
|
|
|a Vascular surgery
|
| 653 |
|
|
|a Cardiac Surgery
|
| 653 |
|
|
|a Abdominal surgery
|
| 653 |
|
|
|a Vascular Surgery
|
| 653 |
|
|
|a Cardiac surgery
|
| 653 |
|
|
|a Abdominal Surgery
|
| 653 |
|
|
|a Surgery
|
| 700 |
1 |
|
|a Redl, H.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-95513-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 617.55059
|
| 520 |
|
|
|a Fibrin plays a prominent role in wound healing. It has a hemostatic effect, induces cellular response to wound damage, and, by forming strands to build a matrix, assists in neovascularization and fibroblast proliferation. The concept of using clotting substances from human blood for wound manage ment and to achieve hemostasis in bleeding parenchymatous organs can be traced to 1909, when Bergel [1] reported on the hemostatic effect of fibrin powder. In 1915, Grey [3] employed fibrin to control bleeding in neurosurgical operations of the brain. A year later, Harvey [4] used fibrin patches to stop bleeding from parenchy matous organs in general surgery. It took more than two decades for this ingenious idea to be rediscovered. In 1940, Young and Medawar [8] reported on experimental nerve anastomosis by sealing. Similarly, Tarlov and Benjamin [7] reunited nerves with plasma clots in 1943. Tarlov improved the results obtained with clot anastomosing of nerves by avoiding tension at the nerve stumps. In 1944, Cronkite et al. [2] reported on an initial series of eight cases in which fibrinogen and thrombin had been used successfully for anchoring skin grafts
|